StockData
Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc. (TARA) stock

TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$2.34+0.02 (+0.86%)

Close on Nov 18, 2026Market cap $138.28MP/E –Yield –

Protara Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Protara Therapeutics's market cap was $154.80M on Nov 11, 2026, against $284.77M a year earlier. Over the last 5 years it ranged from $14.08M to $340.81M, with a median of $51.82M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$154.80M-24.7%
2025Dec 31, 2025$205.67M+88.8%
2024Dec 31, 2024$108.93M+411.1%
2023Dec 29, 2023$21.31M-29.4%
2022Dec 30, 2022$30.20M-60.2%
2021Dec 31, 2021$75.84M-70.2%
2020Dec 31, 2020$254.73M+3072.3%
2019Dec 31, 2019$8.03M-81.6%
2018Dec 31, 2018$43.63M+30.3%
2017Dec 29, 2017$33.48M+6.2%
2016Dec 30, 2016$31.51M-87.7%
2015Dec 31, 2015$255.60M+10114.7%
2014Dec 31, 2014$2.50M–

More Protara Therapeutics figures

See a number that looks wrong?